Miromatrix Medical Inc. MIRO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

2/7 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 Miromatrix Medical Inc. (MIRO), 包括 29 笔买入 和 18 笔卖出. 内部人买入总额为 $999.39K 内部人卖出总额为 $2.08M.

近期活跃的重要内部人包括 Kattungal Laji, Erb John L, Buckman Paul. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — MIRO

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2024-07-16	Kattungal Laji	Vice President of Quality	处置	80,000	$3.75	$300K	-
2023-12-13	Erb John L	Director	股份退回	25,000	$3.75	$93.75K	-
2023-12-13	Buckman Paul	Director	股份退回	25,000	$3.75	$93.75K	-
2023-12-13	Maag Peter	Director	股份退回	58,368	-	-	-
2023-12-13	Burke William P. Mr.	Director	股份退回	67,413	-	-	-
2023-12-13	Heine Lisa Wipperman	Director	股份退回	67,413	-	-	-
2023-12-13	Ross Jeffrey James	Chief Executive Officer	股份退回	100,000	$3.26	$326K	-
2023-12-13	Douglas James Michael	Chief Financial Officer	股份退回	40,000	$3.26	$130.4K	-
2023-12-12	Erb John L	Director	要约收购（卖出）	56,260	$1.75	$98.46K	54,201
2023-12-12	Buckman Paul	Director	要约收购（卖出）	52,593	$1.75	$92.04K	54,201
2023-12-12	Maag Peter	Director	要约收购（卖出）	62,092	$1.75	$108.66K	58,368
2023-12-12	Burke William P. Mr.	Director	要约收购（卖出）	66,943	$1.75	$117.15K	67,413
2023-12-12	Heine Lisa Wipperman	Director	要约收购（卖出）	66,943	$1.75	$117.15K	67,413
2023-12-12	Ross Jeffrey James	Chief Executive Officer	要约收购（卖出）	308,775	$1.75	$540.36K	87,500
2023-12-12	Douglas James Michael	Chief Financial Officer	要约收购（卖出）	31,250	$1.75	$54.69K	20,000
2023-12-12	United Therapeutics Corp	10 Percent Owner	处置	-	-	-	27,419,228
2023-06-01	Erb John L	Director	限制性股票授予 (RSU)	54,201	-	-	110,461
2023-06-01	Buckman Paul	Director	限制性股票授予 (RSU)	54,201	-	-	106,794
2023-06-01	Maag Peter	Director	限制性股票授予 (RSU)	54,201	-	-	120,460
2023-06-01	Burke William P. Mr.	Director	限制性股票授予 (RSU)	54,201	-	-	134,356
2023-06-01	Heine Lisa Wipperman	Director	限制性股票授予 (RSU)	54,201	-	-	134,356
2023-03-10	Erb John L	Director	知情买入	31,250	$1.60	$50K	56,260
2023-03-10	Buckman Paul	Director	知情买入	31,250	$1.60	$50K	52,593
2023-03-10	Maag Peter	Director	知情买入	31,250	$1.60	$50K	66,259
2023-03-10	Burke William P. Mr.	Director	知情买入	31,250	$1.60	$50K	80,155
2023-03-10	Heine Lisa Wipperman	Director	知情买入	31,250	$1.60	$50K	80,155
2023-03-10	Ross Jeffrey James	Chief Executive Officer	知情买入	31,250	$1.60	$50K	396,276
2023-03-10	Barry John Joseph	Vice President of R&d	知情买入	6,250	$1.60	$10K	35,485
2023-03-10	Douglas James Michael	Chief Financial Officer	知情买入	31,250	$1.60	$50K	51,250
2023-01-13	Ross Jeffrey James	Chief Executive Officer	限制性股票授予 (RSU)	100,000	-	-	100,000
2023-01-13	Barry John Joseph	Vice President of R&d	限制性股票授予 (RSU)	20,000	-	-	20,000
2023-01-13	Douglas James Michael	Chief Financial Officer	限制性股票授予 (RSU)	20,000	-	-	20,000
2022-12-06	Ross Jeffrey James	Chief Executive Officer	期权行权（卖出）	37,500	-	-	-
2022-10-01	Barry John Joseph	Vice President of R&d	RSU 预扣税	765	$4.38	$3.35K	19,235
2022-08-10	Erb John L	Director	限制性股票授予 (RSU)	12,788	-	-	25,010
2022-08-10	Buckman Paul	Director	限制性股票授予 (RSU)	12,788	-	-	21,343
2022-08-10	Maag Peter	Director	限制性股票授予 (RSU)	12,788	-	-	35,009
2022-08-10	Burke William P. Mr.	Director	限制性股票授予 (RSU)	12,788	-	-	48,905
2022-08-10	Heine Lisa Wipperman	Director	限制性股票授予 (RSU)	12,788	-	-	48,905
2022-03-15	Ross Jeffrey James	Chief Executive Officer	期权行权	35,438	$1.25	$44.3K	293,588
2022-03-01	Douglas James Michael	Officer	未知	-	-	-	-
2022-03-01	Douglas James Michael	Chief Financial Officer	限制性股票授予 (RSU)	180,000	-	-	180,000
2022-01-13	Niebur Brian	Chief Financial Officer	限制性股票授予 (RSU)	20,000	$4.20	$84K	20,000
2022-01-13	Kattungal Laji	Vice President of Quality	限制性股票授予 (RSU)	10,000	-	-	10,000
2022-01-13	Ross Jeffrey James	Chief Executive Officer	限制性股票授予 (RSU)	100,000	$4.20	$420K	100,000
2022-01-13	Barry John Joseph	Vice President of R&d	限制性股票授予 (RSU)	20,000	$4.20	$84K	20,000
2022-01-03	Niebur Brian	Chief Financial Officer	限制性股票授予 (RSU)	1,500	$4.73	$7.1K	1,500
2022-01-03	Burke William P. Mr.	Director	未知	-	-	-	-
2022-01-03	Burke William P. Mr.	Director	限制性股票授予 (RSU)	4,405	-	-	4,405
2022-01-03	Heine Lisa Wipperman	Director	未知	-	-	-	-